Antonia N. Policheni

Publications

1.8K

Citations

H-Index

2012

Active since

Affiliations

Walter and Eliza Hall Institute of Medical Research(Current)

The University of Melbourne

Monash University

Burnet Institute

Peter Doherty Institute

Antonia N. Policheni is an author at Walter and Eliza Hall Institute of Medical Research specializing in cell signaling, cell biology, and immunology.

ORCID

Top concepts

MedicineImmunologyCell BiologyCell SignalingCell PhysiologySignal TransductionTumor MicroenvironmentCell DeathLung CancerAutoimmunity

Publications per year

2012–2024

Publications

The Dendritic Cell Receptor Clec9A Binds Damaged Cells via Exposed Actin Filaments

Jian‐Guo Zhang, Peter E. Czabotar, Antonia N. Policheni et al. · Immunity · 2012 · 325 citations · Full text

Molecular Immunology, Signal Transduction, Cell Signaling +9

Combined immune checkpoint blockade as a therapeutic strategy for <i>BRCA1</i> -mutated breast cancer

Emma Nolan, Peter Savas, Antonia N. Policheni et al. · Science Translational Medicine · 2017 · 308 citations

Antiapoptotic Mcl-1 is critical for the survival and niche-filling capacity of Foxp3+ regulatory T cells

Wim Pierson, Bénédicte Cauwe, Antonia N. Policheni et al. · Nature Immunology · 2013 · 232 citations · Full text

T-regulatory Cell, Immunology, Niche-filling Capacity +8

Synergy between the KEAP1/NRF2 and PI3K Pathways Drives Non-Small-Cell Lung Cancer with an Altered Immune Microenvironment

Sarah A. Best, David P. De Souza, Ariena Kersbergen et al. · Cell Metabolism · 2018 · 214 citations · Full text

Tumor Biology, Pi3k Pathways, Altered Immune Microenvironment +12

DEC-205 is a cell surface receptor for CpG oligonucleotides

Mireille H. Lahoud, Fatma Ahmet, Jian‐Guo Zhang et al. · Proceedings of the National Academy of Sciences · 2012 · 170 citations · Full text

Cpg Odn, Immunology, Synthetic Cpg Oligonucleotides +19

Rows per page

1–5 of 16